Description

n-(1,3-Benzodioxol-5-Ylmethyl)-2-(3-Oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetamide is a high-purity synthetic organic compound with a complex heterocyclic structure, serving as a critical building block in advanced chemical synthesis. Its value lies in its role as a versatile intermediate for developing novel pharmacologically active molecules, particularly in central nervous system (CNS) and oncology research. This product is essential for R&D chemists and process development scientists in the pharmaceutical, biotechnology, and fine chemical industries seeking to create new therapeutic candidates.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of novel drug candidates targeting neurological disorders and cancer pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities.
• Biochemical Tool Compound: Serves as a reference standard or probe in biological assays to study specific enzyme or receptor interactions.
• Fine Chemical Synthesis: Building block for creating complex molecules with fused quinoxaline and benzodioxole motifs for specialty applications.
• Contract Research & Development (CRO/CMO): Supplied to organizations engaged in custom synthesis and process scale-up for client projects.

Basic Information

Product Name	n-(1,3-Benzodioxol-5-Ylmethyl)-2-(3-Oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetamide
CAS No.	939891-55-1
Molecular Formula	C₁₈H₁₇N₃O₄
Molecular Weight	339.35 g/mol
Synonyms	2-[(3-Oxo-1,2,3,4-tetrahydro-2-quinoxalinyl)acetyl]-1,3-benzodioxole-5-methanamine; N-[(1,3-Benzodioxol-5-yl)methyl]-2-(3-oxo-1,2,3,4-tetrahydro-2-quinoxalinyl)acetamide; 939891-55-1; Quinoxaline-2-acetamide derivative; Benzodioxole acetamide quinoxalinone
EINECS	Contact for details

Quality Control

Our n-(1,3-Benzodioxol-5-Ylmethyl)-2-(3-Oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetamide is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and residual solvent analysis to ensure it meets the stringent requirements for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting full compliance with agreed specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any single impurity ≤ 0.5%, Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.